Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Montelukast Intermediate is a leukotriene receptor antagonist (LTRA). Montelukast Intermediate is used to prevent wheezing, difficulty in breathing, chest tightness, and coughing caused by asthma.
The report details the trend, potential and market size of Montelukast Intermediate market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Montelukast Intermediatemarket, defines the market attractiveness level of Montelukast Intermediate market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Montelukast Intermediate industry, describes the types of Montelukast Intermediate market, the applications of major players and the market size, and deeply analyzes the current situation of the global Montelukast Intermediate market and the development prospects and opportunities of Montelukast Intermediate industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Montelukast Intermediate market in Chapter 13.
By Player:
Ortin Laboratories
PG Shah & Co
VIVAN Life Sciences
Manus Aktteva Biopharma
By Type:
GMP
Non-GMP
By End-User:
Asthma
Allergic Rhinitis
Bronchospasm
Urticaria
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Montelukast Intermediate Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Montelukast Intermediate Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Montelukast Intermediate Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Montelukast Intermediate Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Montelukast Intermediate Market Analysis and Outlook to 2022
-
7.1 Global Montelukast Intermediate Consumption (2017-2022)
-
7.2 United States Montelukast Intermediate Consumption (2017-2022)
-
7.3 Europe Montelukast Intermediate Consumption (2017-2022)
-
7.4 China Montelukast Intermediate Consumption (2017-2022)
-
7.5 Japan Montelukast Intermediate Consumption (2017-2022)
-
7.6 India Montelukast Intermediate Consumption (2017-2022)
-
7.7 South Korea Montelukast Intermediate Consumption (2017-2022)
8 Region and Country-wise Montelukast Intermediate Market Analysis and Outlook to 2028
-
8.1 Global Montelukast Intermediate Consumption Forecast (2022-2028)
-
8.2 United States Montelukast Intermediate Consumption Forecast (2022-2028)
-
8.3 Europe Montelukast Intermediate Consumption Forecast (2022-2028)
-
8.4 China Montelukast Intermediate Consumption Forecast (2022-2028)
-
8.5 Japan Montelukast Intermediate Consumption Forecast (2022-2028)
-
8.6 India Montelukast Intermediate Consumption Forecast (2022-2028)
-
8.7 South Korea Montelukast Intermediate Consumption Forecast (2022-2028)
9 Global Montelukast Intermediate Market Outlook by Types and Applications to 2022
-
9.1 Global Montelukast Intermediate Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global GMP Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-GMP Consumption and Growth Rate (2017-2022)
-
9.2 Global Montelukast Intermediate Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Asthma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Allergic Rhinitis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Bronchospasm Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Urticaria Consumption and Growth Rate (2017-2022)
10 Global Montelukast Intermediate Market Outlook by Types and Applications to 2028
-
10.1 Global Montelukast Intermediate Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global GMP Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-GMP Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Montelukast Intermediate Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Allergic Rhinitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Bronchospasm Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Urticaria Consumption Forecast and Growth Rate (2022-2028)
11 Global Montelukast Intermediate Import and Export Analysis (Top 5 Countries)
-
11.1 Global Montelukast Intermediate Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Montelukast Intermediate Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Montelukast Intermediate Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Montelukast Intermediate Market Competitive Analysis
-
14.1 Ortin Laboratories
-
14.1.1 Ortin Laboratories Company Details
-
14.1.2 Ortin Laboratories Montelukast Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Ortin Laboratories Montelukast Intermediate Product and Service
-
14.2 PG Shah & Co
-
14.2.1 PG Shah & Co Company Details
-
14.2.2 PG Shah & Co Montelukast Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 PG Shah & Co Montelukast Intermediate Product and Service
-
14.3 VIVAN Life Sciences
-
14.3.1 VIVAN Life Sciences Company Details
-
14.3.2 VIVAN Life Sciences Montelukast Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 VIVAN Life Sciences Montelukast Intermediate Product and Service
-
14.4 Manus Aktteva Biopharma
-
14.4.1 Manus Aktteva Biopharma Company Details
-
14.4.2 Manus Aktteva Biopharma Montelukast Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Manus Aktteva Biopharma Montelukast Intermediate Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Montelukast Intermediate
-
Figure Montelukast Intermediate Picture
-
Table Global Montelukast Intermediate Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Montelukast Intermediate Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Montelukast Intermediate Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Montelukast Intermediate Consumption by Country (2017-2022)
-
Figure United States Montelukast Intermediate Consumption and Growth Rate (2017-2022)
-
Table Europe Montelukast Intermediate Consumption and Growth Rate (2017-2022)
-
Figure China Montelukast Intermediate Consumption and Growth Rate (2017-2022)
-
Figure Japan Montelukast Intermediate Consumption and Growth Rate (2017-2022)
-
Figure India Montelukast Intermediate Consumption and Growth Rate (2017-2022)
-
Figure South Korea Montelukast Intermediate Consumption and Growth Rate (2017-2022)
-
Figure Global Montelukast Intermediate Consumption Forecast by Country (2022-2028)
-
Figure United States Montelukast Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Montelukast Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Montelukast Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Montelukast Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Montelukast Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Montelukast Intermediate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GMP Consumption and Growth Rate (2017-2022)
-
Figure Global Non-GMP Consumption and Growth Rate (2017-2022)
-
Figure Global Asthma Consumption and Growth Rate (2017-2022)
-
Figure Global Allergic Rhinitis Consumption and Growth Rate (2017-2022)
-
Figure Global Bronchospasm Consumption and Growth Rate (2017-2022)
-
Figure Global Urticaria Consumption and Growth Rate (2017-2022)
-
Figure Global GMP Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-GMP Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Allergic Rhinitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bronchospasm Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urticaria Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Montelukast Intermediate Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Montelukast Intermediate Export by Region (Top 5 Countries) (2017-2028)
-
Table Ortin Laboratories (Foundation Year, Company Profile and etc.)
-
Table Ortin Laboratories Montelukast Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ortin Laboratories Montelukast Intermediate Product and Service
-
Table PG Shah & Co (Foundation Year, Company Profile and etc.)
-
Table PG Shah & Co Montelukast Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table PG Shah & Co Montelukast Intermediate Product and Service
-
Table VIVAN Life Sciences (Foundation Year, Company Profile and etc.)
-
Table VIVAN Life Sciences Montelukast Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table VIVAN Life Sciences Montelukast Intermediate Product and Service
-
Table Manus Aktteva Biopharma (Foundation Year, Company Profile and etc.)
-
Table Manus Aktteva Biopharma Montelukast Intermediate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Manus Aktteva Biopharma Montelukast Intermediate Product and Service
-
